We are aware of current issues with the ONS login and account creation. At this time, account creation is unavailable. Users who already have an account with ONS should clear their device history/cache before attempting to log in. Thank you.
cancel
Dual Inhibition of ER+ Metastatic Breast Cancer: Anti-hormonal Therapy + CDK4/6 Inhibitor
This resource uses easy to interpret visualize graphics to help better understand the mechanism of action when combining anti-hormonal therapy and a CDK4/6 inhibitor as a dual inhibitor to treat metastatic breast cancer. It takes you from how HR+, HER2- breast cancer grows and how adding in targeted therapies like an anti-hormonal therapy and then a CDK4/6 inhibitor can help stop the growth of the cancer. It also shares safe handling guidance of this combination therapy. This is the perfect handout to hang up on your unit or utilize in the educate your patients on how these drugs fight their specific type of cancer.